OLUTOYIN AKINYANJU: Open Payments
NPI 1093410821 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 16 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| HARMONY BIOSCIENCES LLC | 1 | $42 |
| Corium, LLC | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| TMS NeuroHealth Centers Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
Products named: WAKIX, Azstarys, TRINTELLIX, HETLIOZ, ABILIFY ASIMTUFII, REXULTI, TMS NeuroHealth Centers Inc., Auvelity.
Industry payments across VA — which companies pay providers there.
